We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+10.66%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$1.55B
AUM Growth
+$380M
Cap. Flow
+$243M
Cap. Flow %
15.72%
Top 10 Hldgs %
50.51%
Holding
57
New
12
Increased
9
Reduced
9
Closed
12

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$72.8M
2
HCA icon
HCA Healthcare
HCA
+$69.8M
3
BKD icon
Brookdale Senior Living
BKD
+$48.5M
4
THC icon
Tenet Healthcare
THC
+$32.8M
5
DGX icon
Quest Diagnostics
DGX
+$25.6M

Top Sells

Rank Stock Value
1
CYBX
CYBERONICS INC
CYBX
+$60.8M
2
ESRX
Express Scripts Holding Company
ESRX
+$48.6M
3
CCRN
Cross Country Healthcare
CCRN
+$20.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$20.1M
5
HMSY
HMS Holdings Corp.
HMSY
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 65.24%
2 Consumer Staples 2.55%
3 Technology 2.52%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
1
Teva Pharmaceuticals
TEVA
$40.4B
$118M 7.63%
1,800,000
-200,000
-10% -$12.4M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$102M 6.59%
+500,000
New +$103M
GHDX
3
DELISTED
Genomic Health, Inc.
GHDX
$86.5M 5.59%
2,458,100
+8,100
+0.3% +$217K
MDCO
4
DELISTED
Medicines Co
MDCO
$82.1M 5.31%
2,200,000
-300,000
-12% -$11.3M
LIVN icon
5
LivaNova
LIVN
$4.47B
$71.2M 4.6%
+1,200,000
New +$72.8M
AZN icon
6
AstraZeneca
AZN
$269B
$67.9M 4.39%
1,000,000
-250,000
-20% -$16.4M
HCA icon
7
HCA Healthcare
HCA
$88.4B
$67.6M 4.37%
+1,000,000
New +$69.8M
VTRS icon
8
Viatris
VTRS
$20.8B
$67.6M 4.37%
1,250,000
-250,000
-17% -$12M
NUVA
9
DELISTED
NuVasive, Inc.
NUVA
$59.5M 3.85%
1,100,000
– –
NKTR icon
10
Nektar Therapeutics
NKTR
$2.39B
$59M 3.81%
233,333
+83,333
+56% +$17.1M
OFIX icon
11
Orthofix Medical
OFIX
$492M
$58.8M 3.8%
1,500,000
– –
SEM
12
DELISTED
Select Medical
SEM
$53.6M 3.46%
8,352,000
+278,400
+3% +$1.74M
THC icon
13
Tenet Healthcare
THC
$22.2B
$45.5M 2.94%
1,500,000
+1,000,000
+200% +$32.8M
DGX icon
14
Quest Diagnostics
DGX
$26B
$42.7M 2.76%
600,000
+381,500
+175% +$25.6M
BKD icon
15
Brookdale Senior Living
BKD
$3.55B
$41.5M 2.68%
+2,250,000
New +$48.5M
MASI
16
DELISTED
Masimo
MASI
$41.5M 2.68%
1,000,000
– –
UAM
17
DELISTED
Universal American Corp
UAM
$41.1M 2.66%
5,875,000
– –
MJN
18
DELISTED
Mead Johnson Nutrition Company
MJN
$39.5M 2.55%
500,000
-100,000
-17% -$7.88M
SUNE
19
SUNation Energy
SUNE
$8.91M
$38.9M 2.52%
+4
New +$19.5M
LH icon
20
Labcorp
LH
$25.2B
$37.1M 2.4%
349,200
-116,400
-25% -$12M
BMY icon
21
PUT
Bristol-Myers Squibb
BMY
$129B
$34.4M 2.22%
+500,000
New +$33M
ARIA
22
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$33.8M 2.18%
5,405,235
-127,883
-2% -$839K
SQNM
23
DELISTED
SEQUENOM INC NEW
SQNM
$28.3M 1.83%
17,250,000
+5,500,000
+47% +$9.42M
ARNA
24
DELISTED
Arena Pharmaceuticals Inc
ARNA
$19.9M 1.29%
1,050,000
+75,000
+8% +$1.53M
NVTA
25
DELISTED
Invitae Corporation
NVTA
$16.6M 1.07%
2,024,943
+1,130,929
+127% +$8.9M
1
2 3

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Camber Capital Management held 57 positions worth $1.55B, up 33% from $1.17B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Camber Capital Management deployed $243M of net new capital in Q4 2015, opening 12 new positions and adding to 9 existing holdings. Its largest new stake was LivaNova: 1,200,000 shares worth $71.2M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, down from 72% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was AstraZeneca, an estimated $16.4M trimmed.

  • Camber Capital Management's largest Q4 2015 buy was LivaNova: 1,200,000 shares worth $71.2M.
  • Camber Capital Management added most to Tenet Healthcare in Q4 2015, an estimated $32.8M increase.
  • Camber Capital Management's biggest Q4 2015 reduction was AstraZeneca, cutting an estimated $16.4M.
  • Camber Capital Management fully exited CYBERONICS INC in Q4 2015, selling an estimated $60.8M.
  • Camber Capital Management's ten largest holdings make up 51% of its $1.55B portfolio in Q4 2015.
  • Camber Capital Management opened 12 new positions and closed 12 in Q4 2015.
  • Camber Capital Management's portfolio value rose 33% quarter-over-quarter to $1.55B.

Based on Camber Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.